Bioactive compositions from
View Patent ↗The present invention relates to isolated bioactive compositions containing bioactive fractions derived from Theacea plants. The present invention also relates to bioactive topical formulations containing the bioactive compositions. The present invention further relates to methods of using the bioactive compositions of the present invention, including, for example, methods for inhibiting inflammatory activity in skin tissue of a mammal, for protecting skin tissue of a mammal from ultraviolet light-induced damage, and for normalizing skin disorders in skin tissue of a mammal. The present invention also relates to methods for isolating bioactive fractions derived from cell juice or a cell walls component a Theacea plant.
1. A bioactive composition comprising an isolated bioactive fraction, wherein said isolated bioactive fraction is produced by a process comprising:
(i) providing fresh biomass of a Camellia sinensis plant, wherein said fresh biomass comprises fresh Camellia sinensis plant biomass that has not undergone conventional tea processing;
(ii) separating the fresh biomass of the Camellia sinensis plant into cell juice and a cell walls component, wherein said separating comprises grinding, macerating, and pressing the fresh biomass to separate the fresh biomass into the cell juice and the cell walls component;
(iii) treating the cell juice under conditions effective to yield a bioactive fraction, said conditions comprising subjecting the cell juice to microwave treatment to induce coagulation, thereby yielding a coagulated membrane fraction and a non-coagulated portion of the cell juice, wherein said bioactive fraction is the coagulated membrane fraction; and
(iv) isolating said bioactive fraction from the treated cell juice.
2. The bioactive composition according to claim 1 further comprising a stabilizing agent.
3. The bioactive composition according to claim 2 , wherein said stabilizing agent is selected from the group consisting of an emulsifier, a preservative, an antioxidant, a polymer matrix, and mixtures thereof.
4. A bioactive topical formulation suitable for topical application to a mammal, said bioactive topical formulation comprising:
a topically effective amount of the bioactive composition according to claim 1 and
a topically acceptable carrier.
5. The bioactive topical formulation according to claim 4 , wherein the topically acceptable carrier is selected from the group consisting of a hydrophilic cream base, a hydrophilic lotion base, a hydrophilic surfactant base, a hydrophilic gel base, a hydrophilic solution base, a hydrophobic cream base, a hydrophobic lotion base, a hydrophobic surfactant base, a hydrophobic gel base, and a hydrophobic solution base.
6. The bioactive topical formulation according to claim 4 , wherein the bioactive composition is present in an amount ranging from between about 0.001 percent and about 90 percent of the total weight of the bioactive topical formulation.
7. A bioactive composition comprising an isolated bioactive fraction, wherein said isolated bioactive fraction is produced by a process comprising:
(i) providing fresh biomass of a Camellia sinensis plant, wherein said fresh biomass comprises fresh Camellia sinensis plant biomass that has not undergone conventional tea processing;
(ii) separating the fresh biomass of the Camellia sinensis plant into cell juice and a cell walls component, wherein said separating comprises grinding, macerating, and pressing the fresh biomass to separate the fresh biomass into the cell juice and the cell walls component;
(iii) treating the cell juice under conditions effective to yield a bioactive fraction, said conditions comprising subjecting the cell juice to microwave treatment to induce coagulation, thereby yielding a coagulated membrane fraction and a non-coagulated portion of the cell juice, separating the coagulated membrane fraction from the non-coagulated portion of the cell juice, thereby yielding a coagulated membrane fraction; and
(iv) extracting the membrane fraction with dimethyl sulfoxide, thereby yielding a membrane fraction extract, wherein the bioactive fraction is the membrane fraction extract; and
wherein said membrane fraction extract has a catechin content profile comprising:
between about 1.7 and about 3.3 milligrams of (−)-epigallocatechin per gram of dry matter of the membrane fraction extract,
between about 6.1 and about 10.2 milligrams of (+)-catechin per gram of dry matter of the membrane fraction extract,
between about 0.3 and about 1.1 milligrams of (−)-epicatechin per gram of dry matter of the membrane fraction extract,
between about 6.2 and about 12.5 milligrams of (−)-epigallocatechin gallate per gram of dry matter of the membrane fraction extract,
between about 0.007 and about 0.03 milligrams of (−)-gallocatechin gallate per gram of dry matter of the membrane fraction extract, and
between about 1.3 and about 3.3 milligrams of (−)-epicatechin gallate per gram of dry matter of the membrane fraction extract.
8. The bioactive composition according to claim 7 , further comprising a stabilizing agent.
9. The bioactive composition according to claim 8 , wherein the said stabilizing agent is selected from the group consisting of an emulsifier, a preservative, an antioxidant, a polymer matrix, and mixtures thereof.
10. A bioactive topical formulation suitable for topical application to a mammal, said bioactive topical formulation comprising:
a topically effective amount of the bioactive composition according to claim 7 and
a topically acceptable carrier.
11. The bioactive topical formulation according to claim 10 , wherein the topically acceptable carrier is selected from the group consisting of a hydrophilic cream base, a hydrophilic lotion base, a hydrophilic surfactant base, a hydrophilic gel base, a hydrophilic solution base, a hydrophobic cream base, a hydrophobic lotion base, a hydrophobic surfactant base, a hydrophobic gel base, and a hydrophobic solution base.
12. The bioactive topical formulation according to claim 10 , wherein the bioactive composition is present in an amount ranging from between about 0.001 percent and about 90 percent of the total weight of the bioactive topical formulation.